Research output per year
Research output per year
Fingerprint
Dive into the research topics where Matthew S Block is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research output
-
Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes
Multinu, F., Garzon, S., Weaver, A. L., McGree, M. E., Sartori, E., Landoni, F., Zola, P., Dinoi, G., Aletti, G., Block, M. S., Gadducci, A. & Mariani, A., Apr 1 2021, In: International Journal of Gynecological Cancer. 31, 4, p. 537-544 8 p.Research output: Contribution to journal › Article › peer-review
-
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer
Banville, A. C., Wouters, M. C. A., Oberg, A. L., Goergen, K. M., Maurer, M. J., Milne, K., Ashkani, J., Field, E., Ghesquiere, C., Jones, S. J. M., Block, M. S. & Nelson, B. H., Feb 2021, In: Gynecologic oncology. 160, 2, p. 520-529 10 p.Research output: Contribution to journal › Article › peer-review
-
Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program
Moynagh, M. R., Dowdy, S. C., Welch, B., Glaser, G. E., Schmitz, J. J., Jatoi, A., Langstraat, C. L., Block, M. S., Kurup, A. N. & Kumar, A., Mar 2021, In: Gynecologic oncology. 160, 3, p. 835-843 9 p.Research output: Contribution to journal › Review article › peer-review
-
Sequencing chemotherapy before radiotherapy for women with stage IIIC endometrial cancer
Narasimhulu, D. M., Block, M. S., Weaver, A. L., McGree, M., Kumar, A., Langstraat, C., Petersen, I., Mariani, A. & Glaser, G., 2021, (Accepted/In press) In: International Journal of Gynecological Cancer. 20002158.Research output: Contribution to journal › Article › peer-review
-
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Somaiah, N., Chawla, S. P., Block, M. S., Morris, J. C., Do, K., Kim, J. W., Druta, M., Sankhala, K. K., Hwu, P., Jones, R. L., Gnjatic, S., Kim-Schulze, S., Tuballes, K., Yishak, M., Lu, H., Yakovich, A., Ter Meulen, J., Chen, M., Kenney, R. T., Bohac, C. & 1 others, , Jan 1 2020, In: OncoImmunology. 9, 1, 1847846.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations